Dr Alan Lamont

Dr Alan Lamont

Business Development Manager

Dr. Alan Lamont has been engaged in Corporate and Business Development roles for various companies over the past 20 years, including Acambis (UK/US), AstraZeneca (UK), Eli Lilly (UK/US) and latterly with Mundipharma International Ltd. based in Cambridge, UK. During this time, he has executed deals and established partnerships with a large number of external partners, ranging in type from early, pre-clinical stage, R&D collaborative partnerships, in-licensing/acquisition of clinical stage programmes, through to commercial deals involving on-market products. In his roles at Acambis and Mundipharma, he has also gained significant experience in corporate M&A. He currently also serves as a Non-Executive Director for Synpromics Ltd. (Edinburgh, U.K.).

Meet the teams